المؤلفون: Barbara Radecka, Barbara Ziółkowska, Piotr J. Wysocki, Anton Żawrocki, Jacek Jassem, Anna Kowalczyk, Istvan Lang, Regina Demlová, Wojciech Biernat, Bogumiła Czartoryska-Arłukowicz, Marlena Orlikowska, Renata Duchnowska, Sylwia Dębska-Szmich, Anna Niwińska, Bożenna Karczmarek-Borowska, Małgorzata Foszczyńska-Kłoda, Łukasz Hajac, Maciej Studziński, Monika Merdalska, Paulina Myśliwiec, Konstanty Korski, Dorota Zuziak

المصدر: Oncotarget

مصطلحات موضوعية: 0301 basic medicine, Oncology, epidermal growth factor receptor type 2, Receptor, ErbB-2, medicine.medical_treatment, Estrogen receptor, Kaplan-Meier Estimate, 0302 clinical medicine, Outcome Assessment, Health Care, Epidermal growth factor receptor, lapatinib, Phosphorylation, Aged, 80 and over, biology, Ribosomal Protein S6 Kinases, 70-kDa, Middle Aged, Prognosis, Immunohistochemistry, Receptors, Estrogen, 030220 oncology & carcinogenesis, mTOR, Female, Mitogen-Activated Protein Kinases, medicine.drug, Research Paper, Adult, medicine.medical_specialty, p-MAPK, Breast Neoplasms, Lapatinib, Capecitabine, 03 medical and health sciences, Young Adult, Breast cancer, breast cancer, Predictive Value of Tests, Internal medicine, Cyclin E, medicine, Humans, Protein Kinase Inhibitors, Aged, Proportional Hazards Models, Gynecology, Chemotherapy, business.industry, Cancer, medicine.disease, 030104 developmental biology, biology.protein, Quinazolines, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3d0009831239f320e4bf96d273eb29
http://europepmc.org/articles/PMC4808017